ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Advisors Approve Program To Link Radiation Oncologists.

June 29, 2001

1981 Budget By Funding Mechanism

June 1, 1979

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005

In Brief: “Massive Reassessment” Of Centers Going On, Tim Talbot Believes; WHO Drops ICRB Service

December 9, 1977

In Brief: Louisville Cancer Center Developed With No Federal, State Money Or Fund Raising Costs

May 30, 1980

Poll Finds Voters Support Doubling Of Research Funds.

November 3, 2000